awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q51758312-452C5248-ACC9-4E87-8F27-90643113ADF7
Q51758312-452C5248-ACC9-4E87-8F27-90643113ADF7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51758312-452C5248-ACC9-4E87-8F27-90643113ADF7
Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults.
P2860
Q51758312-452C5248-ACC9-4E87-8F27-90643113ADF7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51758312-452C5248-ACC9-4E87-8F27-90643113ADF7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
eac1fc189947093b549cc3d8da897bc4150ea034
P2860
Calorie restriction mimetics: an emerging research field.